Mereo BioPharma MREO
NASDAQ MREO
$0.29 0.00 (-1.32%)
At close: Oct 21, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Gross Margin (2023 - 2025)

Updated

Mereo BioPharma's Gross Margin came in at 73.40% for FY2025.

Analysis

Mereo BioPharma (MREO) Gross Margin (2023 - 2025) Analysis & Trends

  • Gross Margin carries a four-year change of +22.51 percentage points (FY2021 to FY2025).
  • The FY2025 figure represents the lowest annual Gross Margin since FY2021.
  • Per Business Quant, earlier years put Gross Margin at 74.26% in FY2023 and 50.89% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 85.78%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 68.19%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 74.74%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 73.54%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 78.02%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 83.60%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 72.04%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 79.76%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 72.78%
10 Mereo BioPharma 46.45 Mn -103.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 73.60%
Dec 31, 2023 127.30%
Jun 30, 2023 61.89%
API Access

Mereo BioPharma Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=MREO&period=max&api_key=YOUR_API_KEY